List of Corvus Pharmaceuticals patents

List of Corvus Pharmaceuticals patents

List of ImmunityBio patents

List of Biodesix patents

List of Ribon Therapeutics patents

List of companies in Next Coast Ventures's investment portfolio

List of NGOs in Plymouth, Massachusetts

Patents where

Current Assignee

Name

is

Corvus Pharmaceuticals

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11040040 Methods of treating cancer	Patent 11040040 was granted and assigned to Corvus Pharmaceuticals on June, 2021 by the United States Patent and Trademark Office.	Corvus Pharmaceuticals	Corvus Pharmaceuticals		United States Patent and Trademark Office	11040040	June 22, 2021
	‌ US Patent 10912776 Methods of treating cancer	Patent 10912776 was granted and assigned to Corvus Pharmaceuticals on February, 2021 by the United States Patent and Trademark Office.	Corvus Pharmaceuticals	Corvus Pharmaceuticals		United States Patent and Trademark Office	10912776	February 9, 2021
	‌ US Patent 11266649 Pharmaceutical formulations	Patent 11266649 was granted and assigned to Corvus Pharmaceuticals on March, 2022 by the United States Patent and Trademark Office.	Corvus Pharmaceuticals	Corvus Pharmaceuticals		United States Patent and Trademark Office	11266649	March 8, 2022
	‌ US Patent 11254686 Compounds and methods for modulating adenosine A2B receptor and adenosine A2A receptor	Patent 11254686 was granted and assigned to Corvus Pharmaceuticals on February, 2022 by the United States Patent and Trademark Office.	Corvus Pharmaceuticals	Corvus Pharmaceuticals		United States Patent and Trademark Office	11254686	February 22, 2022
	‌ US Patent 11008314 Compounds and methods for modulating interleukin-2-inducible t-cell kinase	Patent 11008314 was granted and assigned to Corvus Pharmaceuticals on May, 2021 by the United States Patent and Trademark Office.	Corvus Pharmaceuticals	Corvus Pharmaceuticals		United States Patent and Trademark Office	11008314	May 18, 2021
	‌ US Patent 10870652 Compounds and methods for modulating bruton's tyrosine kinase		Corvus Pharmaceuticals	Corvus Pharmaceuticals		United States Patent and Trademark Office	10870652	December 22, 2020
	‌ US Patent 10654825 Processes for making triazolo[4,5D] pyramidine derivatives and intermediates thereof		Corvus Pharmaceuticals	Corvus Pharmaceuticals		United States Patent and Trademark Office	10654825	May 19, 2020
	‌ US Patent 10793636 Anti-CD73 antibodies	Patent 10793636 was granted and assigned to Corvus Pharmaceuticals on October, 2020 by the United States Patent and Trademark Office.	Corvus Pharmaceuticals	Corvus Pharmaceuticals		United States Patent and Trademark Office	10793636	October 6, 2020
	‌ US Patent 12116635 Methods for detecting and treating cancers having adenosine pathway activation	Patent 12116635 was granted and assigned to Corvus Pharmaceuticals on October, 2024 by the United States Patent and Trademark Office.	Corvus Pharmaceuticals	Corvus Pharmaceuticals		United States Patent and Trademark Office	12116635	October 15, 2024
	‌ US Patent 12023337 Methods of treating cancer	Patent 12023337 was granted and assigned to Corvus Pharmaceuticals on July, 2024 by the United States Patent and Trademark Office.	Corvus Pharmaceuticals	Corvus Pharmaceuticals		United States Patent and Trademark Office	12023337	July 2, 2024

10 results

0 selected

10 results

0 selected